BRPI0921027A2 - cepas de vacina de brachyspira hyodysenteriae - Google Patents

cepas de vacina de brachyspira hyodysenteriae

Info

Publication number
BRPI0921027A2
BRPI0921027A2 BRPI0921027A BRPI0921027A BRPI0921027A2 BR PI0921027 A2 BRPI0921027 A2 BR PI0921027A2 BR PI0921027 A BRPI0921027 A BR PI0921027A BR PI0921027 A BRPI0921027 A BR PI0921027A BR PI0921027 A2 BRPI0921027 A2 BR PI0921027A2
Authority
BR
Brazil
Prior art keywords
vaccine strains
brachyspira hyodysenteriae
hyodysenteriae vaccine
brachyspira
strains
Prior art date
Application number
BRPI0921027A
Other languages
English (en)
Inventor
David J Hampson
Matthew I Bellgard
Nyree D Phillips
Tom La
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905922A external-priority patent/AU2008905922A0/en
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BRPI0921027A2 publication Critical patent/BRPI0921027A2/pt
Publication of BRPI0921027A8 publication Critical patent/BRPI0921027A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
BRPI0921027A 2008-11-14 2009-11-13 Cepas de vacina de brachyspira hyodysenteriae BRPI0921027A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008905922A AU2008905922A0 (en) 2008-11-14 Vaccine strains of brachyspira hyodysenteriae
US11550908P 2008-11-17 2008-11-17
PCT/AU2009/001482 WO2010054437A1 (en) 2008-11-14 2009-11-13 Vaccine strains of brachyspira hyodysenteriae

Publications (2)

Publication Number Publication Date
BRPI0921027A2 true BRPI0921027A2 (pt) 2015-12-29
BRPI0921027A8 BRPI0921027A8 (pt) 2017-09-19

Family

ID=42169538

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921027A BRPI0921027A8 (pt) 2008-11-14 2009-11-13 Cepas de vacina de brachyspira hyodysenteriae

Country Status (10)

Country Link
US (1) US9011878B2 (pt)
EP (1) EP2352518A4 (pt)
JP (1) JP2012508564A (pt)
KR (1) KR20110092306A (pt)
CN (1) CN102281893A (pt)
AU (1) AU2009316239B2 (pt)
BR (1) BRPI0921027A8 (pt)
CA (1) CA2743660A1 (pt)
MX (1) MX2011005135A (pt)
WO (1) WO2010054437A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140120946A (ko) * 2007-08-03 2014-10-14 베링거 인겔하임 베트메디카 게엠베하 브라키스피라 하이오디센테리애의 유전자와 단백질 및 이의 용도
HUE059533T2 (hu) 2012-12-21 2022-11-28 Boehringer Ingelheim Vetmedica Gmbh Brachyspira hyodysenteriae-bõl származó új, rekombináns külsõmembrán-proteinek és alkalmazásaik
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
ES2828873T3 (es) * 2013-06-28 2021-05-27 Aquilon Cyl S L Vacuna contra la disentería porcina
RU2018127200A (ru) 2016-01-07 2020-02-07 Университейт Гент Вакцинные штаммы brachyspira hyodysenteriae
AU2018200954B2 (en) * 2017-03-23 2018-11-22 Australasian Pork Research Institute Ltd Live Vaccine Strains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US582655A (en) * 1897-05-18 Apparatus for manufacturing gas
PT549066E (pt) * 1991-12-23 2002-08-30 Dimminaco Ag Vacina de serpulina hyodysenteriae
AU5359298A (en) * 1996-11-12 1998-06-03 Board Of Regents University Of Nebraska Lincoln Attenuated (serpulina hyodysenteriae) mutant for prevention of swine dysentery
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine

Also Published As

Publication number Publication date
CA2743660A1 (en) 2010-05-20
BRPI0921027A8 (pt) 2017-09-19
KR20110092306A (ko) 2011-08-17
US9011878B2 (en) 2015-04-21
CN102281893A (zh) 2011-12-14
EP2352518A4 (en) 2013-07-10
US20110293661A1 (en) 2011-12-01
MX2011005135A (es) 2011-10-24
WO2010054437A1 (en) 2010-05-20
AU2009316239A1 (en) 2010-05-20
JP2012508564A (ja) 2012-04-12
EP2352518A1 (en) 2011-08-10
AU2009316239B2 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
BRPI0919185A2 (pt) ferramenta mecânica
DK2114993T3 (da) Vaccine
BRPI0910283A2 (pt) conjunto de ensacamento
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
EP2334277A4 (en) CRUTCH
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
BRPI0917205A2 (pt) vacina polivalente
BRPI0920240A2 (pt) formulação de adjuvante de combinação
EP2397480A4 (en) DIAZEPINEDIONEDERIVATE
EP2336132A4 (en) MORPHOLINPURINDERIVAT
PT2433722E (pt) Dispositivo de dobragem
BRPI1005919A2 (pt) composição imunogênica
BRPI0906946A2 (pt) Vacinas baseadas em baculovírus
EP2495246A4 (en) FULLER DERIVATIVE
UA19035S (uk) Генератор
EP2515938A4 (en) IMMUNOGENIC COMPOSITIONS
EP2457898A4 (en) FULLER DERIVATIVE
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT
EP2514992A4 (en) STRUT SUPPORT BEARING
EP2492266A4 (en) 5-hydroxypyrimidine-4-carboxamide
EP2207567A4 (en) IMMUNOGENIC FORMULATIONS
BRPI0921027A2 (pt) cepas de vacina de brachyspira hyodysenteriae
BRPI0921578A2 (pt) vacinas unitemporais
BRPI0920833A2 (pt) preparação de benzonorborbenos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SPIROGENE PTY. LTD. (AU)

B25A Requested transfer of rights approved

Owner name: MURDOCH UNIVERSITY (AU)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) , MURDOCH

B25A Requested transfer of rights approved

Owner name: SPIROGENE PTY. LTD. (AU)

B25A Requested transfer of rights approved

Owner name: MURDOCH UNIVERSITY (AU)

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2540 DE 10-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.